VIRTUAL SESSION DATES & TIMES
Saturday, December 5th – 7:00 AM PT/ 9:00 AM CT/ 10:00 AM ET
Saturday, August 22nd – Ended
Wednesday, October 7th – Ended
Registration Fee
We are happy to offer complimentary registration for all online sessions.
Guest Faculty
Thomas A. Albini, MD
University of Miami
Miami, FL
Sophie J. Bakri, MD
Mayo Clinic
Rochester, MN
David S. Boyer, MD
Retina-Vitreous Associates Medical Group
Beverly Hills, CA
David M. Brown, MD
Retina Consultants of Houston
Houston, TX
Peter Campbell, MD, MPH
Casey Eye Institute
Portland, OR
Steve Charles, MD, FACS, FICS
Charles Retina Institute
Germantown, TN
Wiley Chambers, MD
U.S. Food and Drug Administration | FDA · Center for Drug Evaluation and Research
Silver Spring, MD
R.V Paul Chan, MD, MSc, MBA, FACS
Illinois Eye and Ear Infirmary
University of Illinois at Chicago
Chicago, IL
Grace C. Chang, MD, PhD
Oxurion
Iselin, NJ
Emily Y. Chew MD
National Eye Institute
Bethesda, MD
Victor Chong, MBChB, MPhil, MD, FRCS, FRCOphth
University of Oxford
Headington, Oxford
Eugene De Juan, MD
UCSF Health
San Francisco, CA
Dean Eliott, MD
Massachusetts Eye and Ear
Boston, MA
Nancy Holekamp, MD
Pepose Vision Institute
Chesterfield, MO
Allen C. Ho, MD, FACS
Wills Eye Hospital
Philadelphia, PA
Frank G. Holz, MD
University Hospital Bonn
Bonn, Germany
Glenn J. Jaffe, MD
Duke Eye Center
Durham, NC
Peter K. Kaiser, MD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Arshad Khanani MD, MA
Sierra Eye Associates
Reno, NV
Pearse Keane, MD
Moorfields Eye Hospital
London, UK
Judy E. Kim, MD
Medical College of Wisconsin
Milwaukee, WI
Linda A. Lam, MD, MBA
Keck Medicine of USC
Los Angeles, CA
Tamer Mahmoud MD, PhD
Associated Retinal Consultants, PC Royal Oak, MI
Raja Narayanan MD, MBA
LV Prasad Eye Institute
Hyderabad, India
Stephen Odaibo, MD, MS (Math), MS
RETINA-Al Health, Inc.
Houston, TX
Lynne Chou O’Keefe
Define Ventures
San Francisco, CA
Tushar M. Ranchod, MD
Bay Area Retina Associates
Walnut Creek, CA
Philip Rosenfeld, MD, PhD
University of Miami Health
Miami, FL
Michael Singer, MD
Medical Center Ophthalmology Associates
San Antonio , TX
James Anthony Stefater, MD, PhD
Eye Health Services
East Weymouth, MA
Tomasz P. Stryjewski, MD
Tallman Eye Associates
Cambridge, MA
Cynthia A. Toth, MD
Duke Eye Center
Durham, NC
Adnan Tufail, MBBS, MD FRCOphth
Moorfields Eye Hospital
London, UK
Nadia K. Waheed, MD, MPH
Tufts Medical Center
Boston, MA
Charles C. Wykoff, MD, PhD
Retina Consultants of Houston
Houston, TX
David N. Zacks MD, PhD
Kellogg Eye Center
Ann Arbor, MI
Stanford Faculty
Mark S. Blumenkranz, MD
Stanford Health Care
Palo Alto, CA
Eddie Korot, MD
Fellow and Question Moderator
Loh-Shan B. Leung, MD
Stanford Health Care
Palo Alto, CA
Theodore Leng, MD FACS
Stanford Health Care
Palo Alto, CA
Vinit B. Mahajan, MD, PHD
Stanford Health Care
Palo Alto, CA
Kapil Mishra, MD
Fellow and Question Moderator
Darius M. Moshfeghi, MD
Stanford Health Care
Palo Alto, CA
Huy V. Nguyen, MD
Fellow and Question
Moderator
Carolyn Pan, MD
Stanford Health Care
Palo Alto, CA
Nadim Rayess, MD
Stanford Health Care
Palo Alto, CA
Steven Sanislo, MD
Stanford Health Care
Palo Alto, CA
Ira H. Schachar, MD, MSc
Stanford Health Care
Palo Alto, CA
Yasir J. Sepah, MBBS
Stanford Health Care
Palo Alto, CA
Ruwan A. Silva, MD, MPhil
Stanford Health Care
Palo Alto, CA
Edward H. Wood, MD
Stanford Health Care
Palo Alto, CA
Statement of Need/Program Overview
The Stanford Retina Innovation Summit will take place virtually over 3 sessions. The summit series will focus exclusively on the latest, game-changing innovations in medical and surgical retina, imaging, and pharmacotherapy. Topics will include the latest retina pharmacotherapy clinical trials data, updates on artificial intelligence (AI) for diagnosis, advances in molecular surgery for the precision treatment of previously untreatable blinding diseases, and novel drug delivery technologies designed to improve patient care. The program will also focus on the role of imaging in determining new biomarkers for disease. Surgical innovation will be addressed in terms of new instrumentation, visualization enhancements, and image-guided surgery.
This meeting will showcase the journey and insights of leaders in retinal innovation, with the goal of equipping retina specialists to work collaboratively to solve unmet needs for our patients.
Target Audience
The educational design of this activity addresses the needs of practicing retina specialists, retinal fellows in training, and vitreoretinal surgeons involved in the treatment of patients with retinal disease.
Educational Objectives
- Examine the latest clinical data on emerging pharmacotherapeutics in retina
- Evaluate key gene therapy trials for macular and inherited retinal diseases
- Identify strategies for managing inflammation in patients with macular and inherited retinal diseases
- Describe advances in AI and how to integrate AI into clinical practice
- Assess innovations across imaging, medical devices, AI, and pharmacotherapeutics
- Recognize requirements for successful innovation in the academic and private practice settings
- Outline strategies to effectively interact with the FDA as innovators
Topic Highlights
- National and international faculty
- Innovation and retina practice: How you and your partners can achieve more through entrepreneurship
- Hurdles in new drug development: How to combat ocular inflammation
- Next generation therapies coming to your clinic
- Molecular surgery: Is this the future?
- Gene therapy is great: But is it safe?
- Key insights from top innovators in retina
- Game changing therapeutics
- How will Artificial Intelligence change your practice?
- A.I. in retina: Silicon Valley disruption
- Incorporating innovative advances in retinal imaging into clinical practice
Stay Informed
Can't make this event? Subscribe here to stay informed on all upcoming events!
